| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2010PLoSO...5.8856S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0008856 |
| P932 | PMC publication ID | 2810324 |
| P698 | PubMed publication ID | 20111594 |
| P5875 | ResearchGate publication ID | 41174872 |
| P50 | author | Ming Yi | Q55175640 |
| P2093 | author name string | Yulei Wang | |
| Robert Stephens | |||
| Kai C Sonntag | |||
| Filip Simunovic | |||
| P2860 | cites work | Molecular markers of early Parkinson's disease based on gene expression in blood | Q24292810 |
| PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1 | Q24312106 | ||
| Parkin, PINK1, and DJ-1 form a ubiquitin E3 ligase complex promoting unfolded protein degradation | Q24312713 | ||
| High-resolution whole-genome association study of Parkinson disease. | Q24535861 | ||
| Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars | Q24675955 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Genome-wide compensatory changes accompany drug- selected mutations in the Plasmodium falciparum crt gene | Q28472981 | ||
| Fate of midbrain dopaminergic neurons controlled by the engrailed genes | Q28591344 | ||
| Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data | Q28943545 | ||
| Are men at greater risk for Parkinson's disease than women? | Q30433122 | ||
| Genomewide association study for susceptibility genes contributing to familial Parkinson disease | Q30437480 | ||
| A stromal gene signature associated with inflammatory breast cancer. | Q30838525 | ||
| Disturbance of iron metabolism in Parkinson's disease -- ultrasonography as a biomarker | Q33233370 | ||
| Effects of gender on nigral gene expression and parkinson disease | Q33281319 | ||
| SLEPR: a sample-level enrichment-based pathway ranking method -- seeking biological themes through pathway-level consistency | Q33372132 | ||
| Whole genome survey of coding SNPs reveals a reproducible pathway determinant of Parkinson disease | Q33375794 | ||
| Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology | Q33389138 | ||
| Differences in the tumor microenvironment between African-American and European-American breast cancer patients | Q33410258 | ||
| A cross-study transcriptional analysis of Parkinson's disease | Q33420377 | ||
| Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy | Q33450585 | ||
| Seeking unique and common biological themes in multiple gene lists or datasets: pathway pattern extraction pipeline for pathway-level comparative analysis | Q33475893 | ||
| Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity | Q34201593 | ||
| Different microtubule motors move early and late endocytic compartments. | Q52584545 | ||
| Motor neuron degeneration in amyotrophic lateral sclerosis mutant superoxide dismutase-1 transgenic mice: mechanisms of mitochondriopathy and cell death. | Q53588721 | ||
| Parkinson's disease | Q56877819 | ||
| A survey of genetic human cortical gene expression | Q57272923 | ||
| Gender differences in Parkinson's disease | Q57779630 | ||
| Analysis of ferritin genes in Parkinson disease | Q62391452 | ||
| Gender differences in Parkinson's disease | Q64900481 | ||
| CYP450, genetics and Parkinson's disease: gene x environment interactions hold the key | Q79179702 | ||
| Prognosis of Parkinson's disease: time to stage III, IV, V, and to motor fluctuations | Q83957569 | ||
| The biochemistry of Parkinson's disease | Q34426026 | ||
| Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease | Q34598371 | ||
| Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer | Q34803786 | ||
| Programmed cell death and new discoveries in the genetics of parkinsonism. | Q34859364 | ||
| Systematic review of incidence studies of Parkinson's disease | Q35041286 | ||
| Tau protein and neurodegeneration | Q35703317 | ||
| Molecular pathophysiology of Parkinson's disease | Q36196507 | ||
| Chromatin-associated genes protect the yeast genome from Ty1 insertional mutagenesis | Q36391795 | ||
| Nicotine induces brain CYP enzymes: relevance to Parkinson's disease | Q36611512 | ||
| Role of activity-dependent mechanisms in the control of dopaminergic neuron survival | Q36777897 | ||
| Nicotinic receptors as CNS targets for Parkinson's disease | Q36882136 | ||
| Calcium, ageing, and neuronal vulnerability in Parkinson's disease | Q36947731 | ||
| Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer | Q37002626 | ||
| Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies. | Q37050635 | ||
| Gene-targeted therapies for the central nervous system | Q37082309 | ||
| Review: Familial Parkinson's disease--genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease | Q37151410 | ||
| Invited Article: Nervous system pathology in sporadic Parkinson disease | Q37161890 | ||
| Mitochondria in neuroplasticity and neurological disorders | Q37216404 | ||
| Molecular basis of Parkinson's disease | Q37371563 | ||
| Protein misfolding and aggregation in Parkinson's disease. | Q37401276 | ||
| DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders | Q37581184 | ||
| Altered gene expression profiles define pathways in colorectal cancer cell lines affected by celecoxib. | Q38512138 | ||
| Sex and Parkinson's disease: a world of difference? | Q42765835 | ||
| Heterogeneity in male to female risk for Parkinson's disease | Q42765838 | ||
| Tumor immunobiological differences in prostate cancer between African-American and European-American men. | Q44513168 | ||
| Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system | Q45020341 | ||
| Free copper, ferroxidase and SOD1 activities, lipid peroxidation and NO(x) content in the CSF. A different marker profile in four neurodegenerative diseases. | Q45288825 | ||
| Individual dopaminergic neurons show raised iron levels in Parkinson disease. | Q45305197 | ||
| MPP+ impairs autophagic clearance of alpha-synuclein by impairing the activity of dynein. | Q46087817 | ||
| Potassium channels: possible new therapeutic targets in Parkinson's disease | Q46466909 | ||
| Status of antioxidant defense system and expression of toxicant responsive genes in striatum of maneb- and paraquat-induced Parkinson's disease phenotype in mouse: mechanism of neurodegeneration | Q46970444 | ||
| Analysis of alpha-synuclein, dopamine and parkin pathways in neuropathologically confirmed parkinsonian nigra | Q48319369 | ||
| Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity. | Q48405927 | ||
| MRI assessment of basal ganglia iron deposition in Parkinson's disease. | Q48857963 | ||
| Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort. | Q50280290 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| dopamine | Q170304 | ||
| P304 | page(s) | e8856 | |
| P577 | publication date | 2010-01-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease | |
| P478 | volume | 5 |
| Q35738775 | A promoter that drives gene expression preferentially in male transgenic rats |
| Q42778276 | A review of genome-wide transcriptomics studies in Parkinson's disease |
| Q55063113 | A workflow for the integrative transcriptomic description of molecular pathology and the suggestion of normalizing compounds, exemplified by Parkinson's disease. |
| Q35728813 | Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons |
| Q34559477 | Association between GRN rs5848 polymorphism and Parkinson's disease in Taiwanese population |
| Q47120587 | Can we treat neurodegenerative diseases by preventing an age-related decline in microRNA expression? |
| Q47854712 | Cell Type-Specific Laser Capture Microdissection for Gene Expression Profiling in the Human Brain |
| Q92127004 | Common gene expression signatures in Parkinson's disease are driven by changes in cell composition |
| Q30885974 | Computational deconvolution of genome wide expression data from Parkinson's and Huntington's disease brain tissues using population-specific expression analysis |
| Q35911210 | Converging miRNA functions in diverse brain disorders: a case for miR-124 and miR-126. |
| Q34612367 | Current status and future directions of gene expression profiling in Parkinson's disease |
| Q35290033 | Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease |
| Q38765041 | Dicer and microRNAs protect adult dopamine neurons. |
| Q64869052 | Discovery of Novel Cell Surface Markers for Purification of Embryonic Dopamine Progenitors for Transplantation in Parkinson's Disease Animal Models |
| Q37575237 | Do you know the sex of your cells? |
| Q33889585 | Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death. |
| Q38697373 | Gender differences in Parkinson's disease: A clinical perspective |
| Q38074839 | Gender differences in Parkinson's disease: focus on plasma α-synuclein |
| Q35037102 | Gender differences in the risk of familial parkinsonism: beyond LRRK2? |
| Q48898040 | Gender segregation in gene expression and vulnerability to oxidative stress induced injury in ventral mesencephalic cultures of dopamine neurons. |
| Q41624475 | Gender-based analysis of cortical thickness and structural connectivity in Parkinson's disease. |
| Q36069691 | Gene expression in the Parkinson's disease brain |
| Q38034387 | Gene expression profiling in human neurodegenerative disease |
| Q40209615 | Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease |
| Q41617845 | Genetic analysis of indel markers in three loci associated with Parkinson's disease. |
| Q35735221 | Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility |
| Q47205354 | Global mapping of transcription factor motifs in human aging. |
| Q34588477 | Increased DJ-1 in urine exosome of Korean males with Parkinson's disease |
| Q53123768 | Increased extracellular matrix and proangiogenic factor transcription in endothelial cells after cocultivation with primary human osteoblasts. |
| Q37026453 | Limited predictability of postmortem human brain tissue quality by RNA integrity numbers |
| Q37728116 | MicroRNAs and deregulated gene expression networks in neurodegeneration |
| Q88111994 | MicroRNAs in Parkinson's disease |
| Q36853922 | Microfluidic single-cell real-time PCR for comparative analysis of gene expression patterns |
| Q35654904 | Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene network |
| Q33961978 | Neuronal type-specific gene expression profiling and laser-capture microdissection |
| Q35233106 | PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein |
| Q91697836 | Parkinson's Disease in Women and Men: What's the Difference? |
| Q35971342 | Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease. |
| Q38659841 | Prevalence, Duration and Severity of Parkinson's Disease in Germany: A Combined Meta-Analysis from Literature Data and Outpatient Samples |
| Q57035137 | Reduction of HIP2 expression causes motor function impairment and increased vulnerability to dopaminergic degeneration in Parkinson's disease models |
| Q27025107 | Sex differences in Parkinson's disease |
| Q49644664 | Sex differences in Parkinson's disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics. |
| Q92407455 | Sex differences in movement disorders |
| Q37618512 | Sex influences in neurological disorders: case studies and perspectives |
| Q56381130 | Sex-Specific Transcriptome Differences in Substantia Nigra Tissue: A Meta-Analysis of Parkinson's Disease Data |
| Q92351745 | Sex-specific neuroprotection by inhibition of the Y-chromosome gene, SRY, in experimental Parkinson's disease |
| Q37629567 | Sexual dimorphism in Parkinson's disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females |
| Q28396553 | Sexually dimorphic transcriptomic responses in the teleostean hypothalamus: a case study with the organochlorine pesticide dieldrin |
| Q58803418 | Should Exercise Be Prescribed Differently Between Women and Men? An Emphasis on Women Diagnosed With Parkinson's Disease |
| Q36186434 | Single cell genomics of the brain: focus on neuronal diversity and neuropsychiatric diseases. |
| Q30412276 | The effects of perinatal testosterone exposure on the DNA methylome of the mouse brain are late-emerging |
| Q39039214 | The relevance of gender in Parkinson's disease: a review |
| Q40120010 | Transcriptomic Changes in Osteoblasts Following Endothelial Cell-Cocultivation Suggest a Role of Extracellular Matrix in Cellular Interaction. |
| Q37403819 | Widespread sex differences in gene expression and splicing in the adult human brain |
| Q35100268 | miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling. |
Search more.